SWOG clinical trial number
SWOG-9430

A Phase II Trial of Complete Surgical Resection for Stage IV Melanoma-Surgical Resection with Biological and Clinical Follow-Up

70% Accrual
Accrual
70%
Closed
Phase
70% Accrual
Accrual
70%
Published
Abbreviated Title
Surgical Resection for Stage IV Melanoma
Activated
11/15/1996
Closed
11/15/2005
Participants
NCORP, Members, Medical Oncologists, Surgeons, Pathologists, ECOG

Research committees

Melanoma

Treatment

Surgery

Other Clinical Trials

S2000
SWOG Clinical Trial Number

A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases

Research Committee(s)
Melanoma
Activated
09/23/2020
100% Accrual
Accrual
100%
Open
Phase
CTSU/EA6174
SWOG Clinical Trial Number

A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma

Research Committee(s)
Melanoma
Activated
10/01/2018
Open
Phase
CTSU/EA6141
SWOG Clinical Trial Number

Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma

Research Committee(s)
Melanoma
Activated
09/10/2015
Open
Phase